pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
Tyrosine kinase inhibitor (TKIs)
Phase 3 · small molecule · Philadelphia Chromosome Positive Acute Lymphocytic Leukemia
Tyrosine kinase inhibitor (TKIs) for Philadelphia Chromosome Positive Acute Lymphocytic Leukemia is a Phase 3 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code TKI post-HSCT- MRD+Ph+ALL-2018
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Philadelphia Chromosome Positive Acute Lymphocytic Leukemia
- Status
- active
- Trials
- 1